Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

AGM Statement

29 Mar 2023 07:00

RNS Number : 5286U
Versarien PLC
29 March 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

29 March 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

AGM Statement

 

Versarien plc (AIM: VRS), the advanced materials engineering group, will be holding its Annual General Meeting ("AGM") at 10.30 a.m. today, at which the Chair, Diane Savory, will provide the following statement:

 

"As previously noted, the graphene market-place has proved challenging for all participants, but with a streamlined business and a strong focus we believe Versarien has the potential to deliver significant returns from the commercialisation of its technology.

 

Our primary focus is on the construction and textiles sectors, which we believe are at the highest technology readiness level, and where we are already starting to see the emergence of commercial revenues. The launch of Umbro's ProTraining Elite range, including garments incorporating the Company's Graphene-Wear™ technology, has been a particular highlight. Versarien is focussing on its relationships with Umbro, BiaBrazil and Go To Gym as primary opportunities, whilst continuing dialogue with additional sportswear brands.

 

In the construction sector the Company has commissioned its 3D concrete printer and successfully completed several projects, including the 3D printed concrete headwall for use in highway construction projects, part of the Digital Roads of the Future Partnership, a collaboration led by the University of Cambridge, Costain and National Highways, of which Versarien is a partner. CementeneTM, which is our graphene admixture for the construction industry, has also been used in a number of concrete pours, providing validation for the technology and we are pursuing the necessary accreditations to allow full-scale commercialisation.

 

The mature businesses, as previously announced, are no longer core activities for the Company and the Board is evaluating options for divestment to focus solely on exploiting our graphene technology.  In addition, the Board is reviewing its overseas operations in Spain and South Korea.

 

Whilst we remain confident of the commercial benefits of our graphene technology and that it can bring significant returns to Versarien, the Company continues to face a number of challenges that the Board is working hard to overcome.

 

Neill Ricketts resigned as Chief Executive Officer of the Company on 9 March 2023. Neill had led the Company since it was founded and remains a significant shareholder.  Neill is now on garden leave and has ceased to have day-to-day responsibilities, unless required by the Company, but remains a director of Versarien for the duration of his 12 month notice period. The Board would very much like to thank Neill for his contribution and dedication to the Company since its formation and looks forward to his continuing support.

 

Following Neill's resignation, the day-to-day activities of the Company are now being led by the executive directors, Chris Leigh and Steve Hodge, and the Board is actively evaluating both the appropriate longer-term strategy for the Company and the recruitment of a new Chief Executive Officer. To aid the Board in developing both its strategic and management plans, it has engaged experienced strategy and turnaround specialist, David Stone, and his firm Prompt Business Strategies Limited, on a consultancy basis.

 

The Board is also focused on ensuring that the Company has an appropriate cost base for its planned activities and minimising expenditure as far as possible. Significant cost reductions have already occurred, with a reduction in staff numbers and discretionary spend. However, in order to further reduce the Company's cash expenses the non-executive directors, including myself, have agreed to waive any remuneration from the Company indefinitely. The executive directors' pay is also being reviewed.

 

Despite these cost reductions, the Company will require further funding to support its activities. The Board is evaluating all appropriate options, including the proceeds from any disposals, potentially available grant income, possible interest from strategic investors and the potential issue of additional equity, together with the appropriate quantum and timing of any such funding. At this time it is not possible to be more specific on the type of funding that may be secured.

 

In conclusion, I believe that with the continued hard work and dedication of the Versarien team, coupled with the continued support of our partners and investors, we can overcome the challenges we face and successfully commercialise the Company's significant technology base. The Company looks forward to providing further updates in due course."

 

For further information please contact:

 

Versarien

Diane Savory, Non-executive Chair

Chris Leigh, Chief Financial Officer

Stephen Hodge, Chief Technology Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBLGDXBXDDGXI
Date   Source Headline
4th Apr 20178:00 amRNSHolding(s) in Company
21st Mar 20177:00 amRNSCambridge Graphene Update
15th Mar 20179:43 amRNSHolding(s) in Company
9th Mar 20171:00 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSSuccessful Fundraising of £1.5 million
3rd Mar 20174:38 pmRNSFundraising of approximately £1 million
16th Feb 20177:00 amRNSNanene Distribution Agreement
8th Feb 20177:00 amRNSLaunch of Nanene
30th Jan 201710:04 amRNSHolding(s) in Company
19th Jan 20171:21 pmRNSAcquisition and Trading Update
19th Dec 20167:00 amRNSFurther Graphene Enhanced PAEK Plastics Agreement
14th Dec 201610:45 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSGraphene enhanced PAEK Thermoplastics Agreement
29th Nov 20167:01 amRNSInterim Results
29th Nov 20167:00 amRNSSignificant Graphene Order
23rd Nov 20167:00 amRNSNotice of Results
9th Nov 201610:00 amRNSInvestor site visit presentations
31st Oct 20169:15 amRNSDebt for Equity Swap with UoM
27th Oct 20167:00 amRNSNew Healthcare Graphene Project
18th Oct 20167:00 amRNSInvestor Event
13th Oct 20167:00 amRNSCompletion of NGI composite project
3rd Oct 20167:00 amRNSAcquisition of AAC Cyroma
27th Sep 20161:38 pmRNSResult of AGM
1st Sep 201610:36 amRNSNotice of AGM
3rd Aug 20164:25 pmRNSHolding(s) in Company
2nd Aug 20169:53 amRNSHolding(s) in Company
1st Aug 20168:39 amRNSHolding(s) in Company
28th Jul 20162:01 pmRNSHolding(s) in Company
25th Jul 20167:00 amRNSFully subscribed placing to raise £1.1m
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSGraphene Collaboration with CT Engineering
14th Jun 20167:00 amRNSGraphene Collaboration with Absolute Engineering
11th May 20167:00 amRNSGraphene enhanced carbon fibre collaboration
6th Apr 20167:00 amRNSTrading Update
31st Mar 20167:00 amRNS3D Printing with Graphene Trials
11th Mar 20167:00 amRNSResignation of Director
3rd Feb 20167:00 amRNSBoard Changes
11th Dec 20157:00 amRNSDirector Share Purchase
10th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSNotice of Results
4th Nov 20157:00 amRNSChange of Adviser
12th Oct 201511:06 amRNSChange of Registered Office
24th Sep 201511:15 amRNSResult of AGM
21st Sep 20157:00 amRNSVersarien Attending SEC2SV in San Francisco
7th Sep 20157:00 amRNSGrant of US Graphene Patent
19th Aug 20159:53 amRNSAdditional Listing
18th Aug 20152:00 pmRNSPosting of Annual Report
21st Jul 20157:00 amRNSChange of Adviser
21st Jul 20157:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.